Scientific Officer BioAgilytix Overland Park, Kansas
Join Amanda Hays and several authors in Poster Forum #8 in the Solution Center for a conversation about posters on the topic, “Biomarker Advancements in Drug Development”, that she is especially excited about.
W0930-06-33 Receptor Occupancy Assay Development Challenges for Rare Targets of Bispecific Drugs, Jenna Dombroski, Ph.D., Labcorp Biopharma Laboratory Services, Best Abstract Award winner
M0930-10-54 Utilization of Proteomic Surrogates for Early Detection of Unexpected Drug Benefits, Jessica Chadwick, Ph.D., SomaLogic
T1230-06-31 A Technical Evaluation of Targeted Protein Quantification in Formalin Fixed Paraffin Embedded Tumor Sections by Mass Spectrometry Including Antibody Drug Conjugates (ADC), Joseph Eckenrode, Merck & Co., Inc.
M1130-04-24 Excitatory Amino Acid Transporter 2 (EAAT2): A Novel Therapeutic Target for Treatment of Alzheimer’s Disease (AD), Andrew Tang, M.S., University of Arizona
M0930-02-10 Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies, Bhaskarjyoti Sarmah, Ph.D., Moderna, Inc.
